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ABSTRACT
Cholangiocarcinoma is the second most common primary liver malignancy with a global increase of 
incidence and mortality. The mean age at presentation is 50 years. Patients with cholangiocarcinoma usually 
will have symptoms of obstructive jaundice followed with supporting laboratory and imaging findings. The 
predominant clinical feature of extrahepatic cholangiocarcinoma is biliary obstruction resulting in jaundice; 
while intrahepatic cholangiocarcinoma causes symptoms of intrahepatic mass including abdominal pain in right 
upper quadrant and other tumor-related symptoms such as cachexia and malaise. The diagnosis and staging 
of cholangiocarcinoma require multidisciplinary approaches including laboratory, radiological, endoscopic 
approaches and analysis on pathology. 
This case report describes a patient with a cholangiocarcinoma based on results of endoscopic retrograde 
cholangiopancreatography (ERCP) imaging. In addition to a diagnosis tool, ERCP can also be a therapeutic 
modality for placing stent to reduce symptoms of cholestasis. There were supporting laboratory findings such 
as increased bilirubin level, alkaline phosphatase (ALP) and gamma glutamyltransferase (GGT) levels as well 
as increased level of tumor markers such as carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9 
and cytological examination. 
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ABSTRAK
Kolangiokarsinoma merupakan keganasan hati primer kedua yang paling umum, dimana insiden dan 
mortalitasnya meningkat secara global. Usia rata-rata timbulnya gejala adalah 50 tahun. Pasien dengan 
kolangiokarsinoma pada umumnya mengalami gejala ikterus obstruktif disertai dengan hasil laboratorium 
dan pencitraan yang mendukung. Gambaran klinis yang predominan dari kolangiokarsinoma ekstrahepatik 
adalah obstruksi bilier yang menyebabkan ikterus, sedangkan kolangiokarsinoma intrahepatik menimbulkan 
gejala adanya massa intrahepatik yang menyebabkan nyeri kuadran kanan atas abdominal dan gejala terkait 
tumor lainnya yaitu kakeksia dan malaise. Diagnosis dan staging kolangiokarsinoma memerlukan pendekatan 
multidisipliner antara lain laboratorium, radiologis, endoskopi dan analisis patologi.
Pada kasus berikut ini seorang pasien didiagnosa kolangiokarsinoma yang ditegakkan berdasarkan pencitraan 
endoscopic retrograde cholangiopancreatography (ERCP). Selain untuk diagnosis, ERCP menjadi modalitas 
terapi dengan dilakukan pemasangan stent untuk mengurangi gejala kolestasis. Pemeriksaan laboratorium 
yang mendukung antara lain peningkatan bilirubin, alkalin fosfat dan gamma glutamil transferase (GGT), 
peningkatan penanda tumor seperti carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9, dan 
pemeriksaan sitologi. 
Kata kunci: kolangiokarsinoma, ikterus, obstruktif, ERCP
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INTRODUCTION  
Cholangiocarcinoma is a malignant cancer 
that arises from a neoplastic transformation of 
cholangiocytes, the epithelial cells that line intra- and 
extrahepaticbiliarty duct. Cholangiocarcinoma is the 
second most common primary liver malignancy with 
a global increase of incidence and mortality. It has 
specific characteristics with signs of obliterated ducts 
and vasculars. Biliary tract sepsis, liver failure and/or 
cachexia as well as malnutrition are the most essential 
causes of death associated with the tumor.1
The mean age at presentation is 50 years. In western 
countries, the diagnosis of cholangiocarcinoma is made 
at 65 years or more and it is rarely diagnosed before 
40 years of age. In general population, 52-54% of 
cholangiocarcinoma is found in men; however, higher 
mortality is found in women. Different prevalences of 
cholangiocarcinoma among various racial and ethnic 
groups have been reported. The Southeast Asia has the 
highest prevalence.2
Usually, the etiology of cholangiocarcinoma is 
unidentifiable; however, some risk factors can be 
estimated including the primary sclerosing cholangitis. 
Biliary tract cancer is correlated to ulcerative colitis 
with or without sclerosing cholangitis. Thirty percent 
of patients are diagnosed with cholangiocarcinoma 
within a year based on the abnormal results of liver 
function tests. The cancer-related clinical symptoms 
are epigastric pain, weight loss and increased CA 
19-9 and carcinoembryonic antigen (CEA). Moreover, 
worm infection ofhepatobiliary tract also a risk 
factor for cholangiocarcinoma and there is a strong 
correlation with liver fluke species of Opisthorchis 
viverrini and Clonorchis sinensis, particularly in 
East Asia, which has the highest prevalence of 
cholangiocarcinoma and it is an endemic area of liver 
fluke infection due to the habit of eating undercooked 
fish. The flukes are then getting into the biliary duct 
or inside the gall blader. Another risk factor for 
cholangiocarcinoma, which is more typical in Asian 
countries than western countries is hepatolithiasis.2,3 
The following case report will discuss about a 38-year-
old patient with cholangiocarcinoma who presented 
with symptoms of cholestasis, i.e. obstructive jaundice 
with complications of anemia of chronic illness, sepsis 
and acute pancreatitis.
CASE ILLUSTRATION 
A 38-year-old male patient presented with a 
symptom of worsening jaundice since three days 
before hospital admission. There were also dark-
colored urine and clay-colored stool. The patient 
complained aboutabdominal pain on the right upper 
quadrant and the abdomen was slightly enlarged. 
There was also a history of weight loss. Physical 
examination revealed that the patient had moderate 
illness with blood pressure of 120/80 mmHg, pulse 
rate of 84 beats per minute and body temperature at 
36.8o C. His respiratory rate was 18 beats perminute 
and he had moderate nutritional status. Jaundiced 
sclera and hepatomegaly were found. Moreover, 
laboratory workup demonstrated increased bilirubin 
level including total bilirubin of 18.12 mg/dL, direct 
bilirubin of 16.32 mg/dL and indirect bilirubin of 1.80 
mg/dL. There were also increased levels of alkaline 
phosphatase (ALP) and gamma-glutamyltransferase 
(GGT), i.e. the ALP was 539 U/L and the GGT was 
169 U/L, which supported the presence of cholestasis. 
The patient was diagnosed with klastkin tumor and 
andcholangiocarcinoma based on imaging results 
including ultrasonography, computerized tomography 
(CT) scan, esophagogastroduodenoscopy (EGD), 
particularly the ERCP, which showed intra- and 
extrahepatic obstruction and stenosis of coronary heart 
disease (CHD). The pathology anatomy examination 
did not find any evidence of malignant tumor and 
repeated exam was on schedule using brush cytology. 
To manage the symptom of obstructive jaundice, the 
patient was treated with low fat diet, medications 
for stomach problems such as omeprazole (OMZ), 
zompepsin, anti-nausea medicine (domperidone) and 
medicine for cholestasis (urdafalk) and anti-pruritus 
(cefrizin). 
The patient also had other problems including 
anemia with hemoglobin (Hb) level of 12.6 g/dL 
and hematocrit (Ht) level of 37% as well as impaired 
synthesis in the liver, which was characterized by by 
hemostasis disorder with prothrombin time (PT) of 
19.2 seconds and activated partial thromboplastin 
time (APTT) of 52.7 seconds and low albumin level, 
i.e. 3.03 g/dL; there was also dyslipidemia with 
triglyceride level of 334 mg/dL, total cholesterol level 
of 242 mg/dL, high density lipoprotein (HDL) level of 
6 mg/dL and low density lipoprotein (LDL) level 23 
mg/dL. The dyslipidemia in this patient was treated 
with simvastatin and it showed improvement although 
the normal value had not been reached. 
There was also hypokalemia with potassium level of 
3.12 mEq/L, which might be due to lack of food intake 
since the patient had loss of appetite and only had once 
daily meal and the condition was worsen by diarrhea, 
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which occurred at the 16th day of hospitalization. The 
patient was treated with kalium chloride intravenous 
fluid drop (KClIVFD). 
During hospitalization, the patient also had 
experienced acute pancreatitis following his first 
ERCP, which was characterized by increased levels 
of amylase and lipase, i.e. the amylase was 544 U/L; 
while the lipase was 452 U/L. Moreover, the patient 
was treated with clear liquid gastric diet, injections of 
antibiotics (cefoperazone and levofloxacin), gastric 
medication (OMZ), anti-nausea (ondansetron) and 
oral gastric medication (inpepsa®). The patient also 
experienced sepsis, which might be caused by hospital-
acquired pneumonia (HAP) infection. The patient 
was then treated with other antibiotics (meropenem 
and amikacin) and antipyretics (PCT). In 4-5 days the 
symptoms subsided. 
DISCUSSION
Cholangiocarcinoma, which can be also defined 
as Klatskin tumor, is categorized according to its 
anatomical site, i.e. intra- and extrahepatic. The 
extrahepatic type involving the confluence of both 
the left and right hepatic duct is found in 80-90%; 
while the intrahepatic type is found in 5-10% 
in all of cholangiocarcinoma. The anatomical 
margins for differentiating intra- from extrahepatic 
cholangiocarcinoma are the order both biliary ducts. 
The extrahepatic cholangiocarcinoma is then can be 
into types I to IV. Type I: tumor involves common 
hepatic duct distal to the biliary duct; type II: tumor 
involves the biliary; type IIIa: tumor involves the biliary 
and the right hepatic duct; type IIIb: tumor involves the 
biliary and the left hepatic duct; type IV: multifocal or 
tumor involves both the right and left hepatic ducts. 
Histologically, adenocarcinoma is the most common 
pathological form, which accounts for 90% of cases. 
Others papillary adenocarcinoma, intestinal type 
adenocarcinoma, clear cell adenocarcinoma, signet-
ring cell carcinoma, adenosquamous carcinoma, 
squamous cell carcinoma, dan oat cell carcinoma.2
The most common clinical symptom is jaundice 
followed with pruritus, which distinguishing it from 
primary biliary cirrhosis that usually has pruritus 
appearing the most early in the course of the disease. 
Jaundice may occur later when only one of hepatic duct 
is affected. Bilirubin serum level always increases, but 
jaundice may be subsided in 50% patients. The pain 
is usually mild and in the form of epigastric pain. 
Diarrhea may occur as steatorrhea. Weakness and 
weight loss may also happen. Liver is smooth and 
enlargement is palpable at 5-12 cm below the costal 
margin. Spleen is not palpable and ascites rarely occurs. 
Cholangiocarcinoma is usually asymptomatic until 
it reaches advanced level. When symptoms appear, 
predominating clinical symptoms is determined by 
anatomical sites of the tumor. The predominant clinical 
presentation of extrahepaticcholangiocarcinoma is 
biliary obstruction, which results in jaundice; while 
intrahepatic cholangiocarcinoma causes symptoms of 
intrahepatic mass, which produces abdominal pain on 
the right upper quadrant and other tumor-associated 
symptoms such as cachexia and malaise.2,3
The patient had some problems and the most 
dominant was obstructive jaundice supported by 
other clinical symptoms, such as worsening jaundice 
in approximately 3 months, bilirubinuria and clay-
colored stool. There was also bilirubinemia, which 
was particularly characterized by increased levels of 
total, direct and indirect bilirubin; while increased ALP 
and GGT levels indicated the presence of cholestasis. 
Cytological specimens obtained during ERCP 
procdure or percutaneous drainage showed a relatively 
significant results; however cytological expertise 
was required for interpretation. Brush cytology is 
better than analysis of bile aspiration and it has 60% 
sensitivity. Aspiration of fine needle biopsy obtained 
from suspected tumor can also be performed using 
ultrasonography or fluoroscopy. Endoscopic ultrasound-
guided aspiration cytology is also significant, but the 
expertise for interpretation is rare. 
The most studied serum tumor markers are 
carbohydrate antigen (CA) 19-9, carcinoembryonic 
antigen (CEA) and CA 125. CEA and CA-125 are 
not specific and can be increased in gastrointestinal 
or gynecologic malignancies or other bile duct 
pathologies, such as cholangitis and hepatolithiasis. 
CEA is increased in 30% of cholangiocarcinoma 
cases and it can also be increased in inflammatory 
bowel disease, biliary obstruction, other tumor and 
severe liver disease. The concentration of CA 19-9 
serum tumor marker is usually increased in patients 
with biliary tract malignancies. The level may also be 
increased in cholangitis and cholestasis. Its sensitivity 
to detect cholangiocarcinoma in primary sclerosing 
cholangitis is 50-60%. CA 19-9 can not provide 
differentiation between cholangiocarcinoma and 
pancreatic or gastric malignancies. Moreover, it can 
also be increased in severe liver disease due to any 
causes. Combined examination using CA 19-9 and 
CEA do not improve the sensitivity.2,3,4
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The levels of CA 19-9, CEA and CA 125 serum 
tumor marker are increased 85%, 30% and 40-50% 
in patients with cholangiocarcinoma. However, none 
of these markers is specific for cholangiocarcinoma.5 
The tumor marker evaluation performed in this patient 
indicated a normal CEA level, i.e. 4.08 ng/mL and 
increased CA 19-9 level, i.e. 29.9 U/mL.These findings 
supported the diagnosis of malignancy; however, CA 
19-9 level can also be increased due to other causes 
such as severe liver disease. 
The patient already had experienced synthesis 
dysfunction in the liver, which was characterized by 
hemostasis disorder with PT of 19.2 seconds and APTT 
of 52.7 seconds and low albumin level, i.e. 3.03 g/
dLas well as confirmed reduded cholinesterase level, 
i.e. 2,490 U/L. Hemostasis disorder that occurred 
in this patient was caused by reduced synthesis of 
coagulation factors; moreover, the cholestatis in the 
patient also causes vitamin K deficiency. The patient 
was treated with fresh frozen plasma (FFP) transfusion, 
dexamethasone and vitamin K for two days; the 
symptoms of hemostasis disorder improved although 
normal value had not been reached. The laboratory 
workup of complete peripheral blood test indicated 
anemia and the profile of peripheral blood examination 
showed an isopoikilocytosis and target cells. 
In patients with liver disease, an isocytosis can 
be found, i.e. a combination between micro- and 
macrocytosis. However, the patient did not show any 
sign and symptom of gastrointestinal bleeding and 
there was poikilocytosis and cell targets were observed 
due to altered ratio of cholesterol and phospholipid 
in the erythrocyte membrane. These findings are 
particularly found in patients with cholestasis. The 
patient had normocytic normochrome anemia with 
reduced serum iron (SI) and total iron binding capacity 
(TIBC) levels, i.e. SI of 24 ug/dLand TIBC of 182 ug/
dL; while the transferrin saturation was 13%. Increased 
ferritin level, i.e. 1,680 ng/mL indicates the presence 
of acute phase protein of inflammatory process. 
Anemia due to chronic disease usually manifests as 
a mild to moderate normocytic normochromic anemia. 
Patients with such condition have low reticulocyte 
count, which indicate low production of erythrocytes. 
An evaluation on anemia of chronic disease must 
include the determination of iron status in the body to 
exclude iron deficiency anemia, which has microcytic 
hypochromic characteristic. In anemia due to chronic 
disease and iron deficiency, the concentration of serum 
iron level and transferrin saturation are reduced, which 
suggests an absolute iron deficiency in iron deficiency 
anemia and hypoferremia due to iron intake in the 
reticuloendothelial system. In anemia due to chronic 
disease, reduced saturation of transferrin demonstrates 
the low iron level. In iron deficiency anemia, the 
saturation of transferrin can be even lower since the 
serum concentration of iron transporter, the transferrin, 
is increased; while the transferrin level is still normal 
or lower in anemia of chronic disease. Ferritin is used 
as a marker of iron storage, in patients with anemia 
of chronic disease. A normal or increased level of 
ferritin shows increased storage and iron retention in 
reticuloendothelial system.6
Target cells can be found in hepatocellular jaundice 
or cholestasis and they particularly will be obviously 
seen in cholestasis. Increased biliary acid can also be 
a contribution by inhibiting the activity of lecithin 
cholesterol acyl transferase (LCAT).The LCAT of 
erythrocyte membrane is reduced, which produces 
increased cholesterol and lecithin in the membrane. 
Hemostasis disorder in patients with hepatobiliary 
disease is quite complicated due to various changes of 
coagulation pathway resulting in the formation of fibrin 
and also fibrinolysis at the same time.It causes reduced 
coagulation that requires interventional treatment when 
bleeding takes place. Hepatocytes are the main sites 
for synthesis of all proteins of coagulation factors 
except for von Willebrand factor and factor VII C. The 
proteins are vitamin K dependent, i.e. factor II, VII, IX 
and X, as well as factor V, VIII, XI and XII, fibrinogen 
and factor XIII. Vitamin K is a lipid soluble vitamin 
produced by intestinal bacteria. Its deficiency is usually 
caused by cholestasis, either intra- or extrahepatic. In 
cholestasis, parenteral vitamin K supplementation can 
rapidly correct the PT to normal value in 24-48 hours 
and it can be useful for diagnosis. If the coagulopathy 
is caused by liver disease, PT can be improved, but it 
can not reach normal level.7
Cholangiography is one of the most important 
tests in the evaluation of cholangiocarcinoma as it 
can provide earlier diagnosis and can help evaluate 
the proximal and distal extension of intraductal tumor. 
Cholangiography can be performed using endoscopic 
retrograde cholangiopancreatography(ERCP), 
magnetic resonance cholangiopancreatography 
(MRCP) or transcutaneous cholangiography (PTC). 
MRCP has the advantage as it is not invasive 
and there is a possibility of achieiving additional 
information about intra- and extrahepatic anatomical 
structures; while ERCP and PTC have the advantage 
of allowing sampling of bile duct for diagnostic 
analysis and therefore, it can evaluate the presence 
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of biliary obstruction by inserting stents. The choice 
of using imaging modality also depends on tumor 
location. Distal extrahepaticcholangiocarcinoma can 
be optimally evaluated using ERCP. Sometimes, 
hilarcholangiocarcinoma can only be managed by 
placing percutaneous stent.2
An evaluation using ERCP is not always without 
complication. The incidence of acute pancreatitis 
following ERCP procedure varies approximately 
2-9%. Abdominal pain can be a symptom of acute 
pancreatitis and it should be treated with hospital 
care for at least 2 days and serum amylase level can 
be increased at least 3 times above the normal value 
at 24 hours. The etiologies may include mechanical, 
chemical, thermal, hydrostatic injury as well as allergy 
and infection to pancreas. Usually, the patients at risk 
are female patients with young age, dysfunction of 
spinchter of Oddi, recurrent pancreatitis, pancreatic 
sphincterotomy, balloon dilatation in an intact bililary 
sphincter and difficult cannulation with or without 
access to sphincterotomy. Prevention measures 
include selecting patients carefully, recognizing 
risk factors and painstaking attention to technique 
and procedures of placing the pancreatic stents. 
Medications such as antibiotics, nitroglycerin, non-
steroid anti-inflammatory drugs (NSAID), gabexate 
and somatostatin can be used as prophylaxis for 
preventing ERCP-induced pancreatitis.8,9
Acute pancreatitis experienced by the patient was 
due to complication of the ERCP procedure that had 
been performed. The patient had epigastric pain, 
increased amylase and lipase levels of  > 3 times on the 
following day and it was back to normal value 2 days 
later. The patient’s condition was improved in 3 days 
later, particularly after intubation of nasogastric tube 
(NGT).Afterwards, the second ERCP was performed 
and plastic stent was placed and there were improved 
cholestasis symptoms. 
The patient was diagnosed with HAP based on data 
that he had dyspnea during hospitalization and the 
physical examination revealed crackles and the chest 
X-ray suggested bronchopneumonia. It is concluded 
that the patient had experienced HAP since the 
pneumonia occurred within more than 48 hours after 
hospital admission without previous signs of infection 
prior to hospitalization. Pneumonia is one of the most 
common nosocomial infections that occur during 
hospitalization. HAP is defined as pneumonia that 
occurs 48 hours or more after hospital admission and 
the signs and symptoms of infection were not present 
at the time of admission. It is essential to differentiate 
HAP with community-acquired pneumonia (CAP) 
since patients with HAP are susceptible for pneumonia 
caused by more virulent microorganisms. Pathogenesis 
of HAP is multifactorial including recurrent illness 
that causes the patient must be hospitalized, which 
increases the risk for nosocomial infection. Immune 
disorder may also allow pathogenic microorganisms 
to cause invasive infections, which are less likely to 
occur in healthy individuals. Moreover, hospitalized 
patients sometimes have poor nutritional status 
and therefore, it will increase the risk of infection. 
Aspiration of oropharyngeal secretion has an essential 
role in the development of HAP. About 45% of all 
healthy individuals can experience aspiration during 
their sleep. However, with a combination of low 
immune function, disrupted clearance of mucocillia of 
respiratory tract and more pathogenic microorganism, 
the oropharynx of hospitalized patients can be 
colonized by pathogenic Gram-negative bacteria. The 
risk factors for the pathogenic infection are hospital 
length of stay, smoking, elderly age, uremia, previous 
antibiotic exposure, alcohol consumption, endotracheal 
intubation, coma, major surgery, malnutrition, multiple 
organ failure and neutropenia. HAP can be divided 
into 2 categories, i.e. early onset HAP (develops in 
< 5 days since the time of hospital admission) and late 
onset (develops in 5 days or more since admission). 
The most common Gram-positive cocci causing 
pneumonia in hospitalized patients are Streptococcus 
pneumoniae and Streptococcus aureus. S. pneumoniae is 
the most common cause of CAP; therefore, it is more likely 
to be correlated with early onset HAP than late onset CAP. 
Moreover, the early-onset HAP due to Gram-negative 
bacteria is commonly caused by Hemophilus influenzae 
and lactose fermenter such as Enterobactericeae. 
Enterobactericeae is Gram-negative bacteria that causes 
lactose fermentation, i.e. Escherchia coli, Klebsiella spp. 
and Enterobacter spp.10,11
The patient also experienced fever, dyspnea 
and cough and his leukocyte count was 20,500/µL; 
therefore, a diagnosis of sepsis was made. Sepsis is a 
systemic inflammatory process induced by infection 
with various spectrums starting from systemic 
inflammatory response syndrome (SIRS) to multiple 
organ dysfunction syndrome (MODS). SIRS can be 
diagnosed when there are two of the following criteria: 
body temperature is < 36oC or > 38oC, pulse rate is > 
90 times per minute, respiratory rate is > 20 times per 
minute or pCO2 is < 32 mmHg and leukocyte count is < 
4,000/µL or > 12,000/µL or with the presence of > 10% 
immature neutrophils. Sepsis is SIRS accompanied 
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with infection, either confirmed or suspected. It is 
induced by body impairment, which may include 
ischemia, inflammation, injury or infection. In healthy 
individuals, neuroendocrine and immune system will 
eradicate them; however, if the control mechanism 
fails, the condition of patient can be worse and it turns 
into sepsis. The inflammatory process that takes place 
is very complicated involving cellular and humoral 
response, complements and cytokines. Some mediators 
are involved including platelet activating factor (PAF), 
tumor necrosis factor alpha (TNFα), interleukin 1,6,8 
and 10. The most common cause of sepsis is bacterial 
infection; however, infections caused by virus, fungi 
and parasites also should be considered.12 Urinalysis 
on the 2nd day of hospitalization indicated bilirubinuria. 
Afterwards, on the 17th and 22nd day, there was 
proteinuria of positive 1 result and trace blood / Hb. 
The proteinuria that occurred in the patient may be a 
transient proteinuria since the patient had a fever.
The blood gas analysis showed acid pH, low pO2, 
low HCO
3
 and negative base excess. The measured 
anion gap was 22.7 mmol/L. The results indicated that 
the patient had metabolic acidosis with increased anion 
gap, which suggests that there was unmeasured anion, 
in this case, the lactate, that may occur in patients who 
experience sepsis. Bile fluid culture was performed to 
find out the source of sepsis, which revealed results of 
Pseudomonas sp. Infection caused by Pseudomonas 
sp. is usually an opportunistic infection, other 
possibility includes contaminant of ERCP instruments. 
Pseudomonas sp. can be found naturally in water 
and it can be the cause of contaminant on surgical 
instruments, which are introduced into the body. 
The pathology anatomy (PA) examination did not 
reveal the presence of malignant tumor and repeated 
brush cytology was on schedule. It may occur since 
it might not be a representative sampling. In addition, 
negative results of tumor cells in PA examination do not 
exclude the possibility of malignancy as there is still 
a possibility that the tumor is undetected. The patient 
was discharged from hospital after his cholestasis 
symptoms had been managed and other problems such 
as sepsis and acute pancreatitis improved. Afterwards, 
the patient was scheduled for outpatient care. 
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